The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Conservation of the Chk1 Checkpoint Pathway in Mammals: Linkage of DNA Damage to Cdk Regulation Through Cdc25
Abstract
In response to DNA damage, mammalian cells prevent cell cycle progression through the control of critical cell cycle regulators. A human gene was identified that encodes the protein Chk1, a homolog of the Schizosaccharomyces pombe Chk1 protein kinase, which is required for the DNA damage checkpoint. Human Chk1 protein was modified in response to DNA damage. In vitro Chk1 bound to and phosphorylated the dual-specificity protein phosphatases Cdc25A, Cdc25B, and Cdc25C, which control cell cycle transitions by dephosphorylating cyclin-dependent kinases. Chk1 phosphorylates Cdc25C on serine-216. As shown in an accompanying paper by Peng et al . in this issue, serine-216 phosphorylation creates a binding site for 14-3-3 protein and inhibits function of the phosphatase. These results suggest a model whereby in response to DNA damage, Chk1 phosphorylates and inhibits Cdc25C, thus preventing activation of the Cdc2–cyclin B complex and mitotic entry.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The phosphorylation of Chk1 enhances Chk1’s kinase activity, which in turn phosphorylates downstream substrates (e.g., Cdc25, BLM, and FANCD2/FANCE) and facilitates cell cycle arrest and DNA damage repair [91–93].”
From Functional interplay between ATM/ATR-mediated DNA damage response and DNA repair pathways in oxidative stress (2014) · cites this paper as [91]
Citations
Cites
Kozak, M. (1986) · Cell · doi:10.1016/0092-8674(86)90762-2 · Cited by 4,741
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
Self-citationCell Cycle Checkpoints: Preventing an Identity Crisis
Elledge, S. J. (1996) · Science · doi:10.1126/science.274.5293.1664 · Cited by 2,050
Self-citationPeng, C.-Y., Graves, P. R., Thoma, R. S., Wu, Z., Shaw, A. S., & Piwnica-Worms, H. (1997) · Science · doi:10.1126/science.277.5331.1501 · Cited by 1,341
Self-citationRadiation-induced cell cycle arrest compromised by p21 deficiency
Brugarolas, J., Chandrasekaran, C., Gordon, J. I., Beach, D., Jacks, T., & Hannon, G. J. (1995) · Nature · doi:10.1038/377552a0 · Cited by 1,242
Wodarz, A., Hinz, U., Engelbert, M., & Knust, E. (1995) · Cell · doi:10.1016/0092-8674(95)90053-5 · Cited by 661
Enoch, T., & Nurse, P. (1990) · Cell · doi:10.1016/0092-8674(90)90669-6 · Cited by 460
Fission yeast chkl protein kinase links the rad checkpoint pathway to cdc2
Walworth, N. C., Davey, S. K., & Beach, D. (1993) · Nature · doi:10.1038/363368a0 · Cited by 455
Chk1 is a wee1 kinase in the G2 DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation
O’Connell, M. J., Raleigh, J., Verkade, H. M., & Nurse, P. (1997) · The EMBO Journal · doi:10.1093/emboj/16.3.545 · Cited by 398
rad -Dependent Response of the chk1 -Encoded Protein Kinase at the DNA Damage Checkpoint
Walworth, N. C., & Bernards, R. (1996) · Science · doi:10.1126/science.271.5247.353 · Cited by 397
Flagged first, then by citations
Research works printed but not linked: 3
- Waldman T., et al., ibid. 381, 713 (1996).
- Vorechovsky I., et al., Cancer Res. 56, 2726 (1996);
- Lakin N. D., et al., Oncogene 13, 2707 (1996).
Cited by
Sorted by citations
Items 601–700 of 1,000
Requirement of MTA1 in ATR-mediated DNA Damage Checkpoint Function
Li, D., Ohshiro, K., Khan, M. N., & Kumar, R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.085258 · Cited by 44
14-3-3 Protein Signaling in Development and Growth Factor Responses
Thomas, D., Guthridge, M. A., Woodcock, J. M., & Lopez, A. F. (2005) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(05)67009-3 · Cited by 43
Dual Regulation of Cdc25A by Chk1 and p53-ATF3 in DNA Replication Checkpoint Control
Demidova, A. R., Aau, M. Y., Li, Z., & Yu, Q. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m808118200 · Cited by 43
Impaired tissue growth is mediated by checkpoint kinase 1 (CHK1) in the integrated stress response
Malzer, E., Daly, M., Moloney, A. M., Sendall, T. J., Thomas, S. E., Ryder, E. J., Ryoo, H. D., Crowther, D. C., Lomas, D. A., & Marciniak, S. J. (2010) · Journal of Cell Science · doi:10.1242/jcs.070078 · Cited by 45
Wang, J., Gu, Q., Li, M., Zhang, W., Yang, M., Zou, B., Chan, S., Qiao, L., Jiang, B., Tu, S., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp155 · Cited by 43
ATM-dependent CHK2 Activation Induced by Anticancer Agent, Irofulven
Wang, J., Wiltshire, T. D., Wang, Y., Mikell, C., Burks, J., Cunningham, C., Laar, E. S. V., Waters, S. J., Reed, E., & Wang, W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400015200 · Cited by 44
Phosphatase Type 2A-dependent and -independent Pathways for ATR Phosphorylation of Chk1
Li, G., Elder, R. T., Qin, K., Park, H. U., Liang, D., & Zhao, Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607951200 · Cited by 44
Regulation of the Cdc25A gene by the human papillomavirus Type 16 E7 oncogene
Katich, S., Zerfass, K., & Hoffmann, I. (2001) · Oncogene · doi:10.1038/sj.onc.1204130 · Cited by 43
Chk1 complements the G2/M checkpoint defect and radiosensitivity of ataxia-telangiectasia cells
Chen, P., Gatei, M. H., O’Connell, M. J., Khanna, K. K., Bugg, S. J., Hogg, A., Scott, S. P., Hobson, K., & Lavin, M. F. (1999) · Oncogene · doi:10.1038/sj.onc.1202257 · Cited by 43
Lin, Z. P., Ratner, E., Whicker, M. E., Lee, Y., & Sartorelli, A. C. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0480 · Cited by 45
Cleavage-mediated Activation of Chk1 during Apoptosis
Matsuura, K., Wakasugi, M., Yamashita, K., & Matsunaga, T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803111200 · Cited by 42
Huang, L., Hsieh, B.-S., Cheng, H.-L., Hu, Y.-C., Chang, W., & Chang, K. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.11.001 · Cited by 42
Ganzinelli, M., Carrassa, L., Crippa, F., Tavecchio, M., Broggini, M., & Damia, G. L. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0304 · Cited by 42
Robert, T. E. (2002) · Frontiers in bioscience · doi:10.2741/elder · Cited by 42
Jurvansuu, J., Fragkos, M., Ingemarsdotter, C. K., & Beard, P. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.06.077 · Cited by 42
Ghosh, R., Ott, A. M., Seetharam, D., Slaga, T. J., & Kumar, A. P. (2003) · Melanoma Research · doi:10.1097/00008390-200304000-00003 · Cited by 42
Design of new anticancer therapies targeting cell cycle checkpoint pathways
Sampath, D., & Plunkett, W. K. (2001) · Current Opinion in Oncology · doi:10.1097/00001622-200111000-00011 · Cited by 42
Lee, S. S., Vũ, T. T., Weiss, A. S., & Yeo, G. C. (2023) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2023.151331 · Cited by 43
Li, Q. Q., Wang, G., Huang, F., Li, J. M., Cuff, C. F., & Reed, E. (2013) · Medical Oncology · doi:10.1007/s12032-013-0488-9 · Cited by 41
A Phase 1/2 trial of SRA737 (a Chk1 inhibitor) administered orally in patients with advanced cancer
Kristeleit, R. S., Plummer, R., Jones, R., Carter, L., Blagden, S. P., Sarker, D., Arkenau, H., Evans, T. R. J., Danson, S. J., Symeonides, S. N., et al. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02279-x · Cited by 41
Induction of Cdc25B Regulates Cell Cycle Resumption after Genotoxic Stress
Bansal, P., & Lazo, J. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3685 · Cited by 43
Usui, T., & Petrini, J. H. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611259104 · Cited by 41
Wang, Z., Bhattacharya, N., Meyer, M., Seimiya, H., Tsuruo, T., Tonani, J. A., & Magnuson, N. S. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2370 · Cited by 41
Forbes, K. C., Humphrey, T. C., & Enoch, T. (1998) · Genetics · doi:10.1093/genetics/150.4.1361 · Cited by 41
Hutchins, J. R. A., Dikovskaya, D., & Clarke, P. R. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-02-0061 · Cited by 41
Yeast Mutants As a Model System for Identification of Determinants of Chemosensitivity
Perego, P., Jimenez, G. S., Gatti, L., Howell, S. B., & Zunino, F. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01466-2 · Cited by 41
Lin, N., Xia, P., Kovar, P. J., Park, C., Chen, Z., Zhang, H., Rosenberg, S. H., & Sham, H. L. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.09.064 · Cited by 42
Park, J. K., Jung, H., Park, S. H., Kang, S. Y., Yi, M.-R., Um, H., & Hong, S. H. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.11.069 · Cited by 40
The PARP inhibitor PJ34 causes a PARP1-independent, p21 dependent mitotic arrest
Madison, D. L., Stauffer, D. R., & Lundblad, J. R. (2011) · DNA repair · doi:10.1016/j.dnarep.2011.07.006 · Cited by 42
Autoregulatory Mechanisms of Phosphorylation of Checkpoint Kinase 1
Wang, J., Han, X., & Zhang, Y. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0523 · Cited by 43
Li, G., Jung, K. H., Lee, H., Son, M. K., Seo, J.-H., Hong, S., Jeong, Y., Hong, S., & Hong, S. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.10.013 · Cited by 41
Shaw, L., Sneddon, S., Zeef, L. A. H., Kimber, S. J., & Brison, D. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064192 · Cited by 40
Cell-type-specific role of CHK2 in mediating DNA damage-induced G2 cell cycle arrest
van Jaarsveld, M. T. M., Deng, D., Ordoñez‐Rueda, D., Paulsen, M. S., Wiemer, E. A. C., & Zi, Z. (2020) · Oncogenesis · doi:10.1038/s41389-020-0219-y · Cited by 40
ATR-CHK1 pathway as a therapeutic target for acute and chronic leukemias
Boudný, M., & Trbušek, M. (2020) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2020.102026 · Cited by 41
Lee, S. I., Brown, M. K., & Eastman, A. R. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00258-0 · Cited by 40
Mos positively regulates Xe-Wee1 to lengthen the first mitotic cell cycle of XenopusPreprint
Murakami, M. S., Copeland, T. D., & Woude, G. F. V. (1999) · Genes & Development · doi:10.1101/gad.13.5.620 · Cited by 40
Herrick, J., & Bensimon, A. (2008) · Chromosoma · doi:10.1007/s00412-007-0145-1 · Cited by 40
Momeny, M., Moghaddaskho, F., Gortany, N. K., Yousefi, H., Sabourinejad, Z., Zarrinrad, G., Mirshahvaladi, S., Eyvani, H., Barghi, F., Ahmadinia, L., et al. (2017) · Scientific Reports · doi:10.1038/srep44075 · Cited by 39
G1 and S-Phase Checkpoints, Chromosome Instability, and Cancer
Nojima, H. (2004) · Humana Press eBooks · doi:10.1385/1-59259-788-2:003 · Cited by 39
Tong, Y., Claiborne, A. K., Stewart, K. D., Park, C., Kovar, P. J., Chen, Z., Credo, R. B., Gu, W., Gwaltney, S. L., Judge, R. A., et al. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.01.012 · Cited by 39
Mitomycin–DNA Adducts Induce p53-Dependent and p53-Independent Cell Death Pathways
Boamah, E. K., White, D. E., Talbott, K. E., Arva, N. C., Berman, D., Tomasz, M., & Bargonetti, J. (2007) · ACS Chemical Biology · doi:10.1021/cb700060t · Cited by 39
Herman-Antosiewicz, A., Kim, Y.-A., Kim, S., Xiao, D., & Singh, S. V. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0060-7 · Cited by 39
HRad17 Colocalizes with NHP2L1 in the Nucleolus and Redistributes after UV Irradiation
Chang, M.-S., Sasaki, H., Campbell, M. S., Kraeft, S., Sutherland, R., Yang, C., Liu, Y., Auclair, D., Hao, L., Sonoda, H., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.51.36544 · Cited by 39
Cdc25 as a Potential Target of Anticancer Agents
Eckstein, J. W. (2000) · Investigational New Drugs · doi:10.1023/a:1006377913494 · Cited by 39
Hashiguchi, Y., Tsuda, H., Inoue, T., Nishimura, S., Suzuki, T., & Kawamura, N. (2004) · Human Pathology · doi:10.1016/j.humpath.2003.07.018 · Cited by 39
Tessema, M., Lehmann, U., & Kreipe, H. H. (2004) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-003-0971-3 · Cited by 39
DNA damage and cell cycle control in Schizosaccharomyces pombe
Humphrey, T. (2000) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(00)00051-8 · Cited by 39
de Vries, H. I., Uyetake, L., Lemstra, W., Brunsting, J. F., Su, T. T., Kampinga, H. H., & Sibon, O. C. M. (2005) · Journal of Cell Science · doi:10.1242/jcs.02309 · Cited by 39
USP7 Regulates Cytokinesis through FBXO38 and KIF20B
Georges, A. A., Coyaud, É., Marcon, E., Greenblatt, J. F., Raught, B., & Frappier, L. (2019) · Scientific Reports · doi:10.1038/s41598-019-39368-y · Cited by 42
Cell cycle control during early embryogenesis
Brantley, S. E., & Talia, S. D. (2021) · Development · doi:10.1242/dev.193128 · Cited by 40
Jiang, Z., Jin, S., Yalowich, J. C., Brown, K. D., & Rajasekaran, B. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0627 · Cited by 38
Multiple Roles of BRIT1/MCPH1 in DNA Damage Response, DNA Repair, and Cancer Suppression
Lin, S., Liang, Y., & Li, K. (2010) · Yonsei Medical Journal · doi:10.3349/ymj.2010.51.3.295 · Cited by 40
c-Myc alters the DNA damage-induced G2/M arrest in human mammary epithelial cells
Sheen, J.-H., Woo, J.-K., & Dickson, R. B. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601307 · Cited by 38
Loss of heterozygosity at 11q23.1 and survival in breast cancer: Results of a large European study
Laake, K., Launonen, V., Niederacher, D., Gudlaugsdottir, S., Seitz, S., Rio, P. G., Champ�me, M.-H., Bièche, I., Birnbaum, D., White, G. R. M., et al. (1999) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199907)25:3 · Cited by 38
Bouças, J., Fritz, C., Schmitt, A., Riabinska, A., Thelen, L., Peifer, M., Leeser, U., Nüernberg, P., Altmueller, J., Gaestel, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125745 · Cited by 37
Nuclear Chk1 prevents premature mitotic entry
Matsuyama, M., Goto, H., Kasahara, K., Kawakami, Y., Nakanishi, M., Kiyono, T., Goshima, N., & Inagaki, M. (2011) · Journal of Cell Science · doi:10.1242/jcs.086488 · Cited by 38
dos Santos, D. C., Rafique, J., Saba, S., Grinevicius, V. M. A. S., Filho, D. W., Zamoner, A., Braga, A. L., Pedrosa, R. C., & Ourique, F. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3710449 · Cited by 37
Lin, Z. P., Belcourt, M. F., Carbone, R., Eaton, J. S., Penketh, P. G., Shadel, G. S., Cory, J. G., & Sartorelli, A. C. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.11.014 · Cited by 38
Response to DNA damage: why do we need to focus on protein phosphatases?
Shimada, M., & Nakanishi, M. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00008 · Cited by 38
E2F4 Function in G2 Maintaining G2-arrest to Prevent Mitotic Entry with Damaged DNA
Plesca, D. C., Crosby, M. E., Gupta, D., & Almasan, A. (2007) · Cell Cycle · doi:10.4161/cc.6.10.4259 · Cited by 37
Repression of mRNA for the PLK cell cycle gene after DNA damage requires BRCA1
Ree, A. H., Bratland, Å., Nome, R. V., Stokke, T., & Fodstad, Ø. (2003) · Oncogene · doi:10.1038/sj.onc.1207000 · Cited by 38
Thorn, T., Gniadecki, R., Petersen, A., Vičanová, J., & Wulf, H. C. (2001) · Free Radical Research · doi:10.1080/10715760100300921 · Cited by 37
Yeast perspectives on HIV-1 VPR
Zhao, Y. (2000) · Frontiers in bioscience · doi:10.2741/a559 · Cited by 37
A multi-scale map of protein assemblies in the DNA damage response
Kratz, A., Kim, M., Kelly, M. R., Zheng, F., Koczor, C. A., Li, J., Ono, K., Qin, Y., Churas, C., Chen, J., et al. (2023) · Cell Systems · doi:10.1016/j.cels.2023.04.007 · Cited by 36
Qi, W., Zhang, W., Edwards, H. J., Chu, R. L., Madlambayan, G. J., Taub, J. W., Wang, Z., Wang, Y., Li, C., Lin, H., et al. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1095406 · Cited by 36
Yan, L., Donze, J. R., & Liu, L. (2005) · Oncogene · doi:10.1038/sj.onc.1208250 · Cited by 36
Höglund, A., Nilsson, L. M., Forshell, L. P., Maclean, K. H., & Nilsson, J. A. (2009) · Blood · doi:10.1182/blood-2008-10-183475 · Cited by 36
Kelly, R. M., & Davey, S. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0085859 · Cited by 36
Structure-Specific Endonucleases and the Resolution of Chromosome Underreplication
Falquet, B., & Rass, U. (2019) · Genes · doi:10.3390/genes10030232 · Cited by 36
Lethal and Non-Lethal Functions of Caspases in the DNA Damage Response
Lopez, K. E., & Bouchier‐Hayes, L. (2022) · Cells · doi:10.3390/cells11121887 · Cited by 38
Fungal Malformins Inhibit Bleomycin-Induced G2 Checkpoint in Jurkat Cells
Hagimori, K., Fukuda, T., Hasegawa, Y., Ōmura, S., & Tomoda, H. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.1379 · Cited by 36
Kino, T., & Chrousos, G. P. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1321.013 · Cited by 36
Yuan, L., Yu, W., & Qu, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305075200 · Cited by 36
Study of the cytolethal distending toxin (CDT)‐activated cell cycle checkpoint
Alby, F., Mazars, R., de Rycke, J., Guillou, E., Baldin, V., Darbon, J.-M., & Ducommun, B. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02205-0 · Cited by 38
Wang, G., Niu, X., Zhang, W., Caldwell, J. T., Edwards, H. J., Chen, W., Taub, J. W., Zhao, L., & Ge, Y. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.10.015 · Cited by 35
Telles, E., Hosing, A. S., Kundu, S. T., Venkatraman, P., & Dalal, S. N. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.01.018 · Cited by 35
Novel Insights into Chk1 Regulation by Phosphorylation
Goto, H., Kasahara, K., & Inagaki, M. (2014) · Cell Structure and Function · doi:10.1247/csf.14017 · Cited by 37
Alterations of Chk1 and Chk2 expression in colon cancer
Stawińska, M., Cygankiewicz, A. I., Trzciński, R., Mik, M., Dziki, A. J., & Krajewska, W. M. (2008) · International Journal of Colorectal Disease · doi:10.1007/s00384-008-0551-8 · Cited by 36
Parvovirus-Induced Depletion of Cyclin B1 Prevents Mitotic Entry of Infected Cells
Adeyemi, R. O., & Pintel, D. J. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003891 · Cited by 37
Cyclin E Deregulation Impairs Mitotic Progression through Premature Activation of Cdc25C
Bagheri‐Yarmand, R., Nanos-Webb, A., Biernacka, A., Bui, T. N., & Keyomarsi, K. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4095 · Cited by 35
Stanford, J. S., & RUDERMAN, J. V. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-06-0541 · Cited by 35
Dissection of the XChk1 Signaling Pathway inXenopus laevisEmbryos
Kappas, N. C., Savage, P., Chen, K. C., Walls, A. T., & Sible, J. C. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.9.3101 · Cited by 35
Comess, K. M., Trumbull, J. D., Park, C., Chen, Z., Judge, R. A., Voorbach, M. J., Coen, M. L., Gao, L., Tang, H., Kovar, P. J., et al. (2006) · SLAS DISCOVERY · doi:10.1177/1087057106289972 · Cited by 35
Cell cycle-dependent potentiation of cisplatin by UCN-01 in non-small-cell lung carcinoma
Mack, P. C., Gandara, D. R., Lau, A. H., Lara, P. N., Edelman, M. J., & Gumerlock, P. H. (2003) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-003-0571-6 · Cited by 37
Identification of a region of frequent loss of heterozygosity at 11q24 in colorectal cancer.
Connolly, K. C., Gabra, H., Millwater, C. J., Taylor, K. J., Rabiasz, G. J., Watson, J. E. V., Smyth, J. F., Wyllie, A. H., & Jodrell, D. I. (1999) · PubMed · Cited by 35
The Cdk inhibitor flavopiridol enhances temozolomide-induced cytotoxicity in human glioma cells
Hayashi, T., Adachi, K., Ohba, S., & Hirose, Y. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1220-5 · Cited by 34
Wilson, D. W., Lamé, M. W., Dunston, S. K., & Segall, H. J. (2000) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2000.8966 · Cited by 34
The accumulation of DNA repair defects is the molecular origin of carcinogenesis
Cha, H., & Yim, H. (2013) · Tumor Biology · doi:10.1007/s13277-013-1038-y · Cited by 34
al-Ramadi, B. K., Zhang, H., & Bothwell, A. L. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12498 · Cited by 34
Shou, J., Hu, N., Takikita, M., Roth, M. J., Johnson, L. L., Giffen, C. A., Wang, Q., Wang, C., Wang, Y., Su, H. F., et al. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0666 · Cited by 34
The relative contribution of CHK1 and CHK2 to Adriamycin-induced checkpoint
HO, C., Siu, W. Y., Chow, J. P. H., Lau, A. W. S., Arooz, T., TONG, H., Ng, I. O., & Poon, R. Y. C. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.10.016 · Cited by 34
Role of Pin2/TRF1 in telomere maintenance and cell cycle control
Zhou, X. Z., Perrem, K., & Lu, K. P. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10496 · Cited by 34
Fletcher, L., Cheng, Y., & Muschel, R. J. (2002) · PubMed · Cited by 34
Cutting edge: Chk1 directs senescence and mitotic catastrophe in recovery from G2 checkpoint arrest
Poehlmann, A., Habold, C., Walluscheck, D., Reißig, K., Bajbouj, K., Ullrich, O., Hartig, R., Gali‐Muhtasib, H. U., Diestel, A., Roessner, A., et al. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01143.x · Cited by 33
Three independent mechanisms for arrest in G2after ionizing radiation
Landsverk, K. S., Patzke, S., Rein, I. D., Stokke, C., Lyng, H., Angelis, P. M. D., & Stokke, T. (2011) · Cell Cycle · doi:10.4161/cc.10.5.14968 · Cited by 35
Coordinately Targeting Cell-Cycle Checkpoint Functions in Integrated Models of Pancreatic Cancer
Chung, S., Vail, P. J., Witkiewicz, A. K., & Knudsen, E. S. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1620 · Cited by 34
SFPQ Depletion Is Synthetically Lethal with BRAFV600E in Colorectal Cancer Cells
Klotz‐Noack, K., Klinger, B., Rivera, M., Bublitz, N., Uhlitz, F., Riemer, P., Lüthen, M., Sell, T., Kasack, K., Gastl, B., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108184 · Cited by 35
Yong, K. J., Milenic, D. E., Baidoo, K. E., & Brechbiel, M. W. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.09.015 · Cited by 33
Chk1 versus Cdc25: Chking One’s Levels of Cellular Proliferation
Lam, M. H., & Rosen, J. M. (2004) · Cell Cycle · doi:10.4161/cc.3.11.1225 · Cited by 33
Liu, K., Graves, J. D., Scott, J., Li, R., & Lin, W.-C. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00373-13 · Cited by 33
Metadata
- Authors
- Sanchez, Y., Wong, C., Thoma, R. S., Richman, R., Wu, Z., Piwnica-Worms, H., & Elledge, S. J.
- Affiliations
- Y. Sanchez, C. Wong, S. J. Elledge, Verna and Marrs McLean Department of Biochemistry, Department of Molecular and Human Genetics, Howard Hughes Medical Institute, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.
- Howard Hughes Medical Institute (US)
- Venue
- Science
- Published
- 1997-09-05
- Volume
- 277
- Issue
- 5331
- Pages
- 1497-1501
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2105592350
- Cited by
- 1,320
- References
- 24
- Citations by year
- 2026: 11 · 2025: 20 · 2024: 14 · 2023: 32 · 2022: 29 · 2021: 25 · 2020: 30 · 2019: 22 · 2018: 22 · 2017: 35 · 2016: 34 · 2015: 39 · 2014: 29 · 2013: 37 · 2012: 39
- FWCI
- 30.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1f32gm017763-01)
- National Institute of General Medical Sciences (GM-44664, GM17763)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- Chk1, DNA damage checkpoint, Cdc25 phosphatase, cyclin-dependent kinases, cell cycle regulation, 14-3-3 protein binding, mitotic entry, protein kinases, mammalian cells
- MeSH terms
- Checkpoint Kinase 1, F-Box-WD Repeat-Containing Protein 7, Amino Acid Sequence, Animals, Chromosome Mapping, Chromosomes, Human, Pair 11, Cytoskeletal Proteins, DNA Damage, HeLa Cells, Humans, Mitosis, Molecular Sequence Data, Phosphoprotein Phosphatases, Phosphorylation, Phosphoserine, Protein Kinases, Proteins, Recombinant Fusion Proteins, Transfection, Tyrosine 3-Monooxygenase, Signal Transduction, G2 Phase, CDC2 Protein Kinase, Protein Tyrosine Phosphatases, Cell Cycle Proteins, cdc25 Phosphatases, Schizosaccharomyces pombe Proteins, Ubiquitin-Protein Ligases, F-Box Proteins, 14-3-3 Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review